{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T21:14:35Z","timestamp":1762118075887,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.contraception.2012.02.004","type":"journal-article","created":{"date-parts":[[2012,3,23]],"date-time":"2012-03-23T08:16:09Z","timestamp":1332490569000},"page":"359-365","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of efficacy, safety and effects on symptoms of androgenization of a generic oral contraceptive containing chlormadinone acetate 2 mg\/ethinylestradiol 0.03 mg"],"prefix":"10.1016","volume":"86","author":[{"given":"Peyman","family":"Hadji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jutta","family":"Biskup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jelena","family":"Boekhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"May","family":"Ziller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Bonn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucio","family":"Rovati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2012.02.004_bb0005","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s001290050286","article-title":"Die Zukunft der oralen hormonalen Kontrazeption","volume":"31","author":"Rabe","year":"1998","journal-title":"Gyn\u00e4kologie"},{"author":"Deutsche Gesellschaft f\u00fcr Gyn\u00e4kologie und Geburtshilfe e.V. (DGGG)","key":"10.1016\/j.contraception.2012.02.004_bb0010"},{"key":"10.1016\/j.contraception.2012.02.004_bb0015","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2190\/FQXN-K610-BNY8-UQ0L","article-title":"Social sensitivity and acne: the role of personality in negative social consequences and quality of life","volume":"36","author":"Krejci-Manwaring","year":"2006","journal-title":"Int J Psychiatry Med"},{"key":"10.1016\/j.contraception.2012.02.004_bb0020","first-page":"269","article-title":"The impact of acne: a study of adolescents' attitudes, perception and knowledge","volume":"111","author":"Pearl","year":"1998","journal-title":"N Z Med J"},{"key":"10.1016\/j.contraception.2012.02.004_bb0025","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.contraception.2008.10.017","article-title":"Profile of the progesterone derivative chlormadinone acetate \u2014 pharmacodynamic properties and therapeutic applications","volume":"79","author":"Druckmann","year":"2009","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.contraception.2012.02.004_bb0030","first-page":"CD004425","article-title":"Combined oral contraceptive pills for treatment of acne","volume":"8","author":"Arowojolu","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2012.02.004_bb0035","series-title":"Chlormadinonacetat bei Androgenisierungserscheinungen","first-page":"1","article-title":"Chemie und Pharmakologie von Chlormadinonacetat","author":"Kuhl","year":"1995"},{"key":"10.1016\/j.contraception.2012.02.004_bb0040","first-page":"S60","article-title":"Hormonal antiandrogens in acne treatment","volume":"8","author":"Zouboulis","year":"2010","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.contraception.2012.02.004_bb0045","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000226601","article-title":"Comparative effects of chlormadinone acetate and its 3alpha- and 3beta-hydroxy metabolites on progesterone, androgen and glucocorticoid receptors","volume":"84","author":"Schneider","year":"2009","journal-title":"Pharmacology"},{"key":"10.1016\/j.contraception.2012.02.004_bb0050","series-title":"Kontrazeption","first-page":"28","article-title":"Pharmakologie der Gestagene","author":"Kuhl","year":"1999"},{"key":"10.1016\/j.contraception.2012.02.004_bb0055","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2165\/11532910-000000000-00000","article-title":"Six-month evaluation of the benefits of the low-dose combined oral contraceptive chlormadinone acetate 2 mg\/ethinylestradiol 0.03 mg in young women: results of the prospective, observational, non-interventional, multicentre TeeNIS study","volume":"30","author":"Anthuber","year":"2010","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.contraception.2012.02.004_bb0060","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.contraception.2009.02.016","article-title":"Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara) in moderate acne resolution: a randomized, double-blind, placebo-controlled phase III trial","volume":"80","author":"Plewig","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.02.004_bb0065","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0010-7824(98)00008-0","article-title":"Efficacy and safety of the new antiandrogenic oral contraceptive Belara","volume":"57","author":"Zahradnik","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.02.004_bb0070","first-page":"651","article-title":"Bioequivalence study of generic tablet formulations containing ethinylestradiol and chlormadinone acetate in healthy female volunteers","volume":"59","author":"Bonn","year":"2009","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.contraception.2012.02.004_bb0075","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0010-7824(99)00109-2","article-title":"Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: a randomized trial of 20 \u03bcg and 35 \u03bcg estrogen preparations","volume":"60","author":"Rosenberg","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.02.004_bb0080","first-page":"CD003989","article-title":"20 \u03bcg versus >20 \u03bcg estrogen combined oral contraceptives for contraception","volume":"4","author":"Gallo","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2012.02.004_bb0085","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2165\/00044011-200222040-00002","article-title":"Contraceptive efficacy and tolerability of chlormadinone acetate 2 mg\/ ethinylestradiol 0.03 mg (Belara\u00ae). Results of a post-marketing surveillance study","volume":"22","author":"Schramm","year":"2002","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.contraception.2012.02.004_bb0090","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0010-7824(90)90078-A","article-title":"The influence of different combined oral contraceptives on the prevalence and severity of dysmenorrhea","volume":"42","author":"Milsom","year":"1990","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.02.004_bb0095","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1542\/peds.68.5.661","article-title":"Epidemiology of adolescent dysmenorrhea","volume":"68","author":"Klein","year":"1981","journal-title":"Pediatrics"},{"key":"10.1016\/j.contraception.2012.02.004_bb0100","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/01.AOG.0000230214.26638.0c","article-title":"Dysmenorrhea \u2014 advances in pathogenesis and management","volume":"108","author":"Dawood","year":"2006","journal-title":"Obstet Gynaecol"},{"issue":"4","key":"10.1016\/j.contraception.2012.02.004_bb0105","first-page":"CD002120","article-title":"Oral contraceptive pill for primary dysmenorrhoea","author":"Wong","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2012.02.004_bb0110","doi-asserted-by":"crossref","first-page":"783","DOI":"10.2165\/0044011-200828120-00006","article-title":"Effect of an oral contraceptive with chlormadinone acetate on depressive mood: analysis of data from four observational studies","volume":"28","author":"Huber","year":"2008","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.contraception.2012.02.004_bb0115","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJM198304283081701","article-title":"Androgen excess in cystic acne","volume":"308","author":"Marynick","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2012.02.004_bb0120","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/1523-1747.ep12317162","article-title":"Activity of the type 1 5-alpha-reductase exhibits regional differences in isolated sebaceous glands and whole skin","volume":"105","author":"Thiboutot","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.contraception.2012.02.004_bb0125","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000057878","article-title":"Have oral contraceptives reduced the prevalence of acne? A population-based study of acne vulgaris, tobacco smoking and oral contraceptives","volume":"204","author":"Jemec","year":"2002","journal-title":"Dermatology"},{"key":"10.1016\/j.contraception.2012.02.004_bb0130","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1468-3083.2001.00357.x","article-title":"An epidemiological study of acne in female adults: results of a survey conducted in France","volume":"15","author":"Poli","year":"2001","journal-title":"Eur Acad Dermatol Venerol"},{"key":"10.1016\/j.contraception.2012.02.004_bb0135","first-page":"577","article-title":"Prevalence of facial acne in adults","volume":"41","author":"Goulden","year":"1999","journal-title":"Am Acad Dermatol"},{"key":"10.1016\/j.contraception.2012.02.004_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0010-7824(94)90106-6","article-title":"New progesterones in oral contraception","volume":"49","author":"Fotherby","year":"1994","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.02.004_bb0145","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0010-7824(99)00093-1","article-title":"Effect of low-dose oral contraceptives on androgenic markers and acne","volume":"60","author":"Thorneycroft","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.02.004_bb0150","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/09513590009167685","article-title":"Inhibition of skin 5 alpha-reductase by oral contraceptive progestins in vitro","volume":"14","author":"Rabe","year":"2000","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.contraception.2012.02.004_bb0155","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.contraception.2007.03.014","article-title":"Switching hormonal contraceptives to a chlormadinone acetate-containing oral contraceptive. The Contraceptive Switch Study","volume":"76","author":"Schramm","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.02.004_bb0160","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000051701","article-title":"Acne resolution rates: results of a single-blind, randomized, controlled, parallel phase III trial with EE\/CMA (Belara) and EE\/LNG (Microgynon)","volume":"203","author":"Worret","year":"2001","journal-title":"Dermatology"},{"key":"10.1016\/j.contraception.2012.02.004_bb0165","series-title":"Gyn\u00e4kologische Endokrinologie","first-page":"p413","author":"Runnebaum","year":"1994"},{"key":"10.1016\/j.contraception.2012.02.004_bb0170","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.contraception.2007.12.007","volume":"77","author":"Zahradnik","year":"2008","journal-title":"Contraception"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782412000546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782412000546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T21:09:45Z","timestamp":1762117785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782412000546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0010782412000546"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2012.02.004","relation":{},"ISSN":["0010-7824"],"issn-type":[{"type":"print","value":"0010-7824"}],"subject":[],"published":{"date-parts":[[2012,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of efficacy, safety and effects on symptoms of androgenization of a generic oral contraceptive containing chlormadinone acetate 2 mg\/ethinylestradiol 0.03 mg","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2012.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}